Dalhousie University Reports Findings in Health and Medicine (US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics)

Related content

• Research output

• US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics

  Research output: Contribution to journal › Article › peer-review